Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost–Consequence Analysis
- DOI
- 10.3390/jcm15187261
- Published
- 2026-09-18
- Container
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/jcm15187261,
title = {Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost–Consequence Analysis},
author = {Firuz Kh. Turaev and Sherzod P. Abdullaev and Kirill I. Matrenin and Furkatjon S. Gafurov and Svetlana N. Tuchkova and David A. Gabrielyan and Karin B. Mirzaev and Dmitry A. Kaprin and Dmitry A. Sychev},
year = {2026},
journal = {Journal of Clinical Medicine},
doi = {10.3390/jcm15187261},
url = {https://doi.org/10.3390/jcm15187261}
}RIS
TY - JOUR TI - Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost–Consequence Analysis AU - Firuz Kh. Turaev AU - Sherzod P. Abdullaev AU - Kirill I. Matrenin AU - Furkatjon S. Gafurov AU - Svetlana N. Tuchkova AU - David A. Gabrielyan AU - Karin B. Mirzaev AU - Dmitry A. Kaprin AU - Dmitry A. Sychev PY - 2026 JO - Journal of Clinical Medicine DO - 10.3390/jcm15187261 UR - https://doi.org/10.3390/jcm15187261 ER -
APA
Turaev, F. K., Abdullaev, S. P., Matrenin, K. I., Gafurov, F. S., Tuchkova, S. N., Gabrielyan, D. A., Mirzaev, K. B., Kaprin, D. A., & Sychev, D. A. (2026). Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost–Consequence Analysis. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15187261
Source records
- crossref · retrieved 2026-09-26T17:51:03.848Z